Hat mitgewirkt an:
-
Dendritische Zellen-basierte Immuntherapie des hepatozellulären Karzinoms
-
Inhibition der Hepatitis-C-Virus-Translation mittels antisense-RNA kodierender adenoviraler Vektoren der 1. und der 2. Genreration in vivo
-
Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients
-
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with...